About
Mehul Desai, PharmD, serves as Senior Vice-President of Global Medical Affairs and Advocacy at Enable Injections. He drives evidence generation, scientific communications and key opinion leader engagement for the enFuse® technology, while also supporting regulatory approvals and current and prospective partnerships. Dr Desai has extensive experience with rare diseases and has contributed to peer-reviewed journals, trade publications and industry conferences, advancing the science of large-volume biologics administration.
At argenx, he served as Medical Director, advancing strategic direction, clinical trial execution and business development. He also held field medical roles at Alexion Pharmaceuticals and Mallinckrodt Pharmaceuticals, both supporting rare disease portfolios. Dr Desai earned his PharmD from Purdue University (West Lafayette, IN, US) and an MBA in Pharmaceutical and Healthcare Business from the University of the Sciences (Philadelphia, PA, US).
